Kerry Welch
American Fork, UTNPI 1346291796
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 126 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 21.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $700 and has fallen 73.6% since, to $185 in 2022.
Across 126 payments — averaging $14.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$408
- Amgen$282
- Lilly USA, LLC$208
- Takeda Pharmaceuticals U.S.A., Inc.$188
- Sanofi-aventis U.S. LLC$143
- Pfizer$70
- plus $561 from 21 others
What the payments were for
- Food & beverage$1,861100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 23 | $408 |
| Amgen | 18 | $282 |
| Lilly USA, LLC | 14 | $208 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $188 |
| Sanofi-aventis U.S. LLC | 11 | $143 |
| Pfizer | 5 | $70 |
| Upsher-smith Laboratories LLC | 4 | $65 |
| Mannkind Corporation | 3 | $46 |
| Eisai Inc. | 4 | $45 |
| Bayer | 2 | $40 |
| Daiichi Sankyo Inc. | 2 | $37 |
| Indivior Inc. | 2 | $36 |
| Merck | 2 | $33 |
| Novo Nordisk | 2 | $32 |
| Nestle Healthcare Nutrition Inc. | 2 | $28 |
| AstraZeneca | 2 | $28 |
| Arbor Pharmaceuticals, Inc. | 2 | $26 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $25 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
| Boehringer Ingelheim | 1 | $15 |
| Dynavax Technologies Corporation | 1 | $14 |
| Bausch Health US, LLC | 1 | $12 |
| GSK | 1 | $12 |
| Johnson & Johnson | 1 | $12 |
| Organon | 1 | $2 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.